Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Vitullo Nicole
Relationship:   10% Owner
City:   Richmond
State:   CA
   
Insider Summary:
  
   
Companies Owned :   26    
Direct Shares   3,769,432    

Indirect Shares

   2,643,947      
Direct Value   $44,560,195    

Indirect Value

   $8,032,806      
Total Shares   6,413,379      
Total Value   $52,593,002      


Onyx Pharmaceuticals Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $16 Esperion Therapeutics, Inc. $70,144 Aldeyra Therapeutics, Inc. $7,755,419 Marinus Pharmaceuticals Inc $9,051 Syndax Pharmaceuticals Inc $36,725,565 Onyx Pharmaceuticals Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $16 Esperion Therapeutics, Inc. $70,144 Aldeyra Therapeutics, Inc. $7,755,419 Marinus Pharmaceuticals Inc $9,051 Syndax Pharmaceuticals Inc $36,725,565
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -29.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-12 8,000    Premium*  
            Onyx Pharmaceuticals Inc ONXX Director 2005-07-28 668 2005-07-28 0    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-04 3,333    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2006-05-09 100,355    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-28 5,142 2008-04-24 56,718    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 3,019 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN Director 2020-01-28 0 2020-01-28 0    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX Director, 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2023-06-15 36,918 2019-03-21 0    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2017-12-11 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 2016-11-01 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 2014-05-07 1,973,389 2014-05-01 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS Director 2022-02-04 6,442 2021-03-16 0    Premium*  
            Colucid Pharmaceuticals, Inc. CLCD 10% Owner 2016-09-09 0 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 10% Owner 2016-03-08 1,743,854 2016-03-08 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ESPR Esperion Therapeutics, In... Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 36,918 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2022-02-04 4 A $0.00 $0 D/D 2,750 6,442 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2021-05-27 4 A $0.00 $0 D/D 12,376 31,768 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-16 4 A $0.00 $0 D/D 2,717 3,692 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-16 4 D $0.00 $0 I/I (17,804) 0 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-15 4 S $15.87 $67,448 I/I (4,250) 0 0 %
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-12 4 D $0.00 $0 I/I (619,221) 0 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-12 4 A $0.00 $0 I/I 6,192 6,192 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2020-05-28 4 A $0.00 $0 D/D 6,106 19,392 0 -
ACHN Achillion Pharmaceuticals... Director   –       •      –    2020-01-28 4 D $6.30 $21,536,808 I/I (3,418,541) 0 0 -
ACHN Achillion Pharmaceuticals... Director   –       •      –    2020-01-28 4 D $6.30 $229,515 D/D (36,431) 0 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-05-29 4 A $0.00 $0 D/D 4,967 13,286 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-03-21 4 D $0.00 $0 I/I (17,790) 0 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-03-21 4 A $0.00 $0 D/D 1,356 8,319 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-03-19 4 S $44.66 $685,596 I/I (15,329) 0 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-03-19 4 A $0.00 $0 I/I 17,790 17,790 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-03-19 4 D $0.00 $0 I/I (1,101,080) 0 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2018-06-22 4 A $0.00 $0 D/D 3,846 6,963 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2018-06-22 4 D $0.00 $0 I/I (21,471) 0 0 -
ACHN Achillion Pharmaceuticals... Director   –       •      –    2018-05-31 4 D $0.00 $0 I/I (25,000) 0 0 -
ACHN Achillion Pharmaceuticals... Director   –       •      –    2018-05-31 4 A $0.00 $0 D/D 5,000 36,431 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2018-01-26 4 A $0.00 $0 D/D 645 3,177 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2018-01-26 4 D $0.00 $0 I/I (8,500) 0 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2018-01-25 4 S $71.79 $838,076 I/I (11,674) 15,329 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2018-01-24 4 D $0.00 $0 I/I (850,000) 1,037,852 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us